期刊文献+

CD8+T细胞在胃癌组织中的表达及其临床意义 被引量:10

Expression and clinical significance of CD8+ T cells in gastric carcinoma tissues
原文传递
导出
摘要 目的 观察胃癌组织中浸润性淋巴细胞CD8+T的表达及临床作用.方法 应用免疫组织化学染色检测102例胃癌患者手术标本中浸润淋巴细胞CD8+T的表达.结果 在胃癌、胃炎及胃息肉组织中均可见浸润淋巴细胞CD8+T的表达,但胃癌组浸润淋巴细胞CD8+T的表达[(29.53±14.71)个/HPF]明显高于慢性胃炎组[(19.54±8.10)个/HPF]和胃息肉组[(14.26±6.83)个/HPF],差异有统计学意义(P<0.05).CD8+T细胞的表达与胃癌患者的性别、年龄、肿瘤部位、肿瘤大小、淋巴结转移、复发、病理分级和TNM分期无明显相关(P>0.05);但与组织学类型和浸润深度有关,其中分化型胃癌患者CD8+T细胞的表达[(33.9±18.4)个/HPF]高于低分化型患者的表达[(27.6±12.0)个/HPF],差异有统计学意义(t=2.04,P<0.05);未侵入肌层组的CD8+T细胞表达[(38.8±13.8)个/HPF]明显高于侵入肌层组[(27.7±14.1)个/HPF],差异有统计学意义(t=2.45,P<0.05).与CD8+T细胞低表达组比较,CD8+T细胞高表达组胃癌患者中位生存时间延长5个月,但差异无统计学意义(χ2=1.0274,P>0.05).多因素COX模型分析显示,与浸润淋巴细胞CD8+T低表达组比较,高表达组有降低胃癌死亡风险的趋势(RR=0.82,95%CI=0.41~1.65).结论 浸润性淋巴细胞CD8+T的表达与胃癌的预后有关. Objective To study the expression and clinical significance of infiltrating lymphocytes CD8 + T in gastric carcinoma tissues.Methods The expression of infiltrating lymphocytes CD8 + T in 102surgically resected specimens of gastric cancer tissues was detected by using immunohistochemistry.Results CD8+ T cells were expressed both in gastric carcinoma,gastritis and gastric polyp tissues,but the number of CD8 + T cells in gastric carcinoma tissues [(29.53 ± 14.71 )/high powered field (HPF)]wassignificantly greater than in gastritis tissues [( 19.54 ±8.10)/HPF]and polyp tissues [( 14.26 ±6.83)/HPF](P 〈0.05).No correlation was found between CD8 + T lymphocyte count and gender,age,tumor location,tumor size,lymph node metastasis,tumor relapse,pathological grade or TNM stage ( P 〉 0.05 ).However,there was a statistically significant correlation between the number of CD8 + T cells and the histological type,invasive depth.The CD8 + T cell count was obviously higher in the differentiated group [(33.9 ± 18.4)/HPF]than in the undifferentiated group [(27.6 ± 12.0)/HPF]( t = 2.04,P〈0.05 ).And the number of CD8 + T cells was greater in the non-invasive group [(38.8 ± 13.8)/HPF]than in the invasive group [(27.7 ± 14.1 )/HPF]( t = 2.45,P〈0.05 ).The median survival time of gastric cancer patients with high expression of CD8 + T cells was 5 months longer than in those with low expression,but there was no significant difference.Multi-factor COX model analysis demonstrated that the risk of death in gastric cancer patients was lower in the CD8 + T cells high expression group than in the low expression group ( RR = 0.82,95%,CI = 0.41-1.65 ).Conclusion Detection of infiltrating lymphocytes CD8 + T expression in gastric carcinoma tissues will be beneficial to the judgment of the prognosis.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第3期361-363,共3页 Chinese Journal of Experimental Surgery
基金 基金项目:国家自然科学基金资助项目(30950022、30972703) 江苏省卫生厅医学科技发展基金资助项目(P200932、P200933) 江苏省卫生厅"科教兴卫工程"开放课题基金资助项目(KF200972) 常州市社会发展计划资助项目(CS20092019)
关键词 胃癌 浸润 淋巴细胞 CD8 Gastric carconoma Infiltrate Lymphocytes CD8
  • 相关文献

参考文献10

  • 1Kennedy R,Celis E.Multiple roles for CD4^+ T cells in anti-tumor immune responses.Immunol Rev,2008,222:129-144.
  • 2Bajtai A,Hidvegi J.The role of gastric mucosal dysplasia in the development of gastric carcinorna.Pathol Oncol Res,1998,4:297-300.
  • 3Pages F,Berger A,Camus M,et al.Effector memory T cells,early metastasis,and survival in colorectal cancer.N Engl J Med,2005,353:2654-2666.
  • 4蒋敬庭,吴昌平,沈月平,朱一蓓,陈陆俊,孙静,胡文蔚,孔炯,吴鸿雅,Lu Binfeng,张学光.共刺激分子B7-H4在胃癌组织中表达及其与预后的关系[J].中华实验外科杂志,2009,26(9):1155-1158. 被引量:29
  • 5Hershberg RM,Mayer LF.Antigen processing and presentation by intestinal epithelial cells-polarity and complexity.Immunol Today,2000,21:123-128.
  • 6Suciu-Foca N,Manavalan JS,Cortesini R.Generation and function of antigen-specific suppressor and regulatory T cells.Transpl Immunol,2003,11:235-244.
  • 7Hamanishi J,Mandai M,Iwasaki M,et al.Programmed cell death 1ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer.Proc Natl Acad Sci USA,2007,104:3360-3365.
  • 8Jiang J,Zhu Y,Wu C,et al.Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer.Cancer Immunol Immunother,2010,59:1707-1714.
  • 9Wu C,Zhu Y,Jiang J,et al.Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance.Acta Histochem,2006,108:19-24.
  • 10蒋敬庭,吴昌平,沈月平,郑璐,吴骏,季枚,郑晓,吴雨岗,朱一蓓,LU Bin-feng,张学光.协同刺激分子B7-H4影响细胞因子诱导的杀伤细胞治疗胃癌预后的多因素COX模型分析[J].中华实验外科杂志,2010,27(5):656-660. 被引量:16

二级参考文献15

  • 1蒋敬庭,吴昌平,邓海峰,陆明洋,李敏,王赫,吴骏.细胞因子诱导的杀伤细胞与肿瘤浸润淋巴细胞体外细胞毒活性比较[J].检验医学,2005,20(4):322-324. 被引量:18
  • 2吴昌平,蒋敬庭,邓海峰,陆明洋,李敏,王赫,吴骏,张红宇,季枚,赵伟庆.CIK细胞体外培养的免疫表型[J].江苏医药,2005,31(9):644-645. 被引量:20
  • 3姚宇锋,项建斌,蔡端.B7反义肽预处理的受体树突状细胞诱导供体特异性的免疫低反应[J].中华实验外科杂志,2006,23(9):1130-1132. 被引量:5
  • 4王琦,蒋敬庭,邓海峰,陆明洋,李敏,徐斌,王赫,吴骏,季枚,赵伟庆,吴昌平.细胞因子诱导的杀伤细胞治疗中晚期胃癌的疗效[J].江苏医药,2007,33(8):800-802. 被引量:13
  • 5Zang X,Loke P,Kim J,et al.B7x:a widely expressed B7 family member that inhibits T cell activation.Proc Natl Acad Sci USA,2003,100:10388-10392.
  • 6Kamimura Y,Kobori H,Piao J,et al.Possible involvement of soluble B7-H4 in T cell-mediated inflammatory immune responses.Biochem Biophys Res Commun,2009,389:349-353.
  • 7Soslow RA,Dannenberg A J,Rush D,et al.COX-2 is expressed in human pulmonary,colonic,and mammary tumors.Cancer,2000,89:2637-2645.
  • 8Jiang J,Xu N,Wu C,et al.Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells.Anticancer Res,2006,26:2237-2242.
  • 9Hansen JD,Du Pasquier L,Lefranc MP,et al.The B7 family of immunoregulatory receptors:a comparative and evolutionary perspective.Mol Immunol,2009,46:457-472.
  • 10Olioso P,Giancola R,Di Riti M,et al.Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours:a pilot clinical trial.Hematol Oncol,2009,27:130-139.

共引文献38

同被引文献106

引证文献10

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部